Tech Company Financing Transactions

ANA Therapeutics Funding Round

On 8/6/2020, ANA Therapeutics raised $5 million in Seed funding from private investors, On Air Investments and Refactor Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

602 Bainbridge St.
Foster City, CA 94404
USA

Phone

Undisclosed

Website

www.anatherapeutics.com

Email Address

[email protected]

Overview

ANA Therapeutics is a developer of a novel coronavirus vaccine intended to save human lives. It is developing therapeutics to solve the coronavirus pandemic using Niclosamide that enables medical practitioners to treat patients suffering from COVID-19. It was founded in 2020 and is headquartered in Foster City, California.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Akash Bakshi

        

Chief Operating Officer

Andrew Bartynski

        

Chief Scientific Officer

Nadja Mannowetz

        

Browse more venture capital transactions:

Prev: 8/6/2020: FleetOps venture capital transaction
Next: 8/6/2020: Kyber Data Science venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary